Use and misuse of antimicrobials on farms: Ecological and health impact Juan J Carrique-Mas Oxford University Clinical Research Unit Ho Chi Minh City, Vietnam Biodiversity and Health Symposium Phnom Penh, 17 November 2014 Agenda • AMR: A complex ‘ecohealth’ problem • Economic development and animal production • The ‘ecological web’ of AMR • Other AMR co-selecting environmental pollutants • Data from current projects (OUCRU-VN): - Antimicrobial consumption - Transmission of AMR between humans and animals • The way forward – Future projects The ‘Confusogram’ ????? J. F. Prescott et al. (2000) Antimicrobial Therapy in Veterinary Medicine The VAC system in Vietnam Source: FAO (2004) Fish andand shrimp production in Vietnam (2004 to 2011) Human farm density in SE Asia* Animal protein consumption: Vietnam Humans * Sources: LEAD and FAO (2000, 2006) Pig farms Chicken farms Antimicrobial use in animal production S. Page and P. Gautier (2012), Rev. sci. tech. Off. int. Epiz., 2012, 31 (1), 145-188 Post antimicrobial effects Fate of antimicrobials Distribution at sub-inhibitory concentrations Fate of antimicrobials Fate of antimicrobial Fateresistant of antimicrobial bacteria resistant bacteria Fate of resistant genes Fate of resistant genes Interaction with • Pathogens and commensals environmental • Direct transfer from host to host • Indirect transfer (food, water, environmental pathways) bacteria? • Vertical transfer • Horizontal transfer between unrelated bacteria *Adapted from Da Costa et al. (2013) Int. J. Environ. Res. Public Health 2013, 10: 278-294 7 AMR and environmental bacteria - Environmental bacteria >95% of the earth’s microbiome - Naturally produce antimicrobials as signalling molecules at low concentrations - Naturally multi-drug resistant - Most plasmid-mediated ARG originate from the environment i.e. qnr from waterborne bacteria - Since 1950’s humans have manufactured antimicrobials and used them at industrial levels, this results in unprecedented levels of exposure of the earth’s microbiome to antimicrobials Ecological concerns • Commensal, pathogenic flora, and ARG interact with environmental organisms in certain hotspots •ARG integrated in gene-transfer elements (plasmids, transposons, integrons) the highest risk Farm, hospital • ARG can be maintained in the absence of antimicrobial selective pressure and co-selected due to other stressors (siderophores, toxins, heavy metals, biocides) Do changes in the natural ecosystems as a consequence of human activities accelerate evolution towards AMR? • ARG detected in bacteria from environmentally pristine locations, indicating dissemination • qnr encoded in plasmids detected in Aeromonas spp. † J. Martinez (2009). Proc. R. Soc. B. Confirmed hospital-acquired Acinetobacter baumannii infections, respiratory patients, ICU (HTD, HCMC (Vietnam) (2000-2014) Year 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Total No. isolates 12 33 37 42 55 24 25 24 5 20 56 53 97 136 619 Amikacin No. R/No. Tested 2/9 15/23 17/37 18/42 26/55 9/24 10/24 9/24 3/5 17/18 45/54 38/49 80/96 106/134 395/594 Imipenem % 22.2% 65.2% 45.9% 42.9% 47.3% 37.5% 41.7% 37.5% 60.0% 94.4% 83.3% 77.6% 83.3% 79.1% 66.5% Source: James I. Campbell, OUCRU-HCMC No. R/No. Tested NT NT 4/37 9/42 14/55 3/24 1/24 2/23 1/5 19/20 41/56 41/51 81/96 120/135 336/602 Colistin % 10.8% 21.4% 25.5% 12.5% 4.2% 8.7% 20.0% 95.0% 73.2% 80.4% 84.4% 88.9% 55.8% No. R/No. Tested NT NT NT NT NT NT NT NT 0/18 2/55 0/48 2/94 4/134 0/1 8/350 % NT NT NT NT NT NT NT NT 0.0% 3.6% 0.0% 2.1% 3.0% 0.0% 2.3% AMR in E. coli in humans and chickens in the Mekong Delta Tien Giang VIBRE Project Rural areas (3 districts) Chicken farm •Knowledge and use of antimicrobials: •Bio-security Chicken farms (N=204) Development of AMR E. coli ? Urban areas (1 city) •Use of antimicrobials •Food habits Non-farmers (N=204) •Not involved in poultry farming •Matched by commune, age/sex to farmer Transfer of AMR? •Use of antimicrobials •Contact with chickens •Food habits Chicken farmers (N=204) Transfer of AMR? •Use of antimicrobials •Food habits Urban inhabitants (N=102) •Not involved in poultry farming •Living in urban centre of My Tho Antimicrobial agents used in chicken farming, TG Class of antimicrobial Name of antimicrobial No. (%) formulations containing the product (N=157) 57 (36.3%) No. (%) farms using (N=208) Tetracyclines Doxycycline, oxytetracycline, tetracycline 53 (25.5%) Polypeptides Colistin 48 (30.6%) 41 (19.7%) Macrolides Tylosin, tilmicosin, erythromycin, spiramycin 40 (25.5%) 40 (19.2%) Penicillins Ampicillin, amoxicillin 41 (26.1%) 34 (16.3%) Quinolones Flumequine, oxolinic acid, norfloxacin, enrofloxacin 22 (14.0%) 19 (9.1%) Aminoglycosides 19 (12.1%) 19 (9.1%) Phenicols Spectinomycin, neomycine, gentamicin, apramycin, streptomycin Florfenicol, thiamphenicol 14 (8.9%) 12 (5.8%) Sulphonamides/ trimethoprim Sulfamethoxazole, sulphadimidine, sulphadimetoxine, sulphadimerazine, trimethoprim 12 (7.6%) 12 (5.8%) Lincosamides Lincomycin 4 (2.5%) 4 (2.5%) Pleuromutilin Tiamulin 1 (0.6%) 1 (0.5%) 13 Penicillins Polipeptides Macrolides Tetracyclines Quinolones Phenicols Aminoglycosides Sulphonamides Lincosamides 6 33 2 1 2 5 3 25 1 13 6 20 No. administrations Pleuromutilins Lincosamides Sulphonamides Aminoglycosides Phenicols Quinolones Tetracyclines Macrolides Polypeptide Penicillin Antimicrobial formulations, TG 1 41 1 3 48 5 4 1 40 7 57 1 22 8 14 1 1 3 3 19 12 1 Pleuromutilin 100/157 (64% products were ‘mixes’ of 2 or more antimicrobials) 4 1 tylosin tartrate, trimethoprim, sulphadiazine, sulphamethoxazole AMU on chicken farms, Tien Giang Variable Number of antimicrobial products used over study period Method of administration Type of administration Timing Advice given by Level 0 1 >1 Water Feed Feed and water Prophylaxis Treatment Both On arrival Continuously Periodic Other Drug seller District veterinarian Friend/neighbour Sales person Other All farms (N=208) 40.9% 40.9% 18.3% 82% 9% 4% 84% 12% 4% 34% 18% 29% 19% 56% 18% 12% 12% 2% Antimicrobial consumption in relation to chicken production Stratum No. farms sampled No. chickens sampled No. chickens (census) Fraction sampled (%) CG, hh CG, sm CT, hh CT, sm MT, hh MT, sm All 34 34 36 36 34 34 208 2,890 47,970 4,505 50,230 2,290 52,500 160,385 409,850 128,250 268,295 56,700 58,310 73,300 994,705 0.007 0.374 0.017 0.886 0.039 0.716 0.161 Milligrams of Grams of active active compound Sampling compound per used per week weight 1,000 chickens per chicken produced (±SE) 141.8 30.4 (±15.6) 901.2 (±622.8) 2.7 5.3 (±1.5) 167.5 (±63.9) 59.5 5.6 (±1.4) 327.8 (±122.4) 1.1 18.6 (±7.2) 193.1 (±57.3) 25.5 26.4 (±17.2) 413.8 (±256.4) 1.4 4.7 (±1.9) 156.6 (±63.7) 15.1 (±4.0) 358.1 (±113.5) 16 What’s on the menu? Colistin: 120 mg/Kg Neomycin: 400 mg/Kg Florfenicol: 60mg/Kg Kitasamycin: 300 mg/Kg In Vietnam, most commercial animal feed rations are medicated AMR testing in E. coli 1 ampicillin (10µg) 2 ceftriaxone (30µg) 3 ceftazidime (30µg) 4 chloramphenicol (30µg) 5 ciprofloxacin (1µg) 6 ciprofloxacin (5µg) 7 trimethoprim-sulphamethoxazole (1.25 µg /23.75µg) 8 gentamicin (10µg) 9 amikacin (30µg) 10 meropenem (10µg) 11 amoxicillin-clavulanic acid (20/10µg) 12 tetracycline (30µg) Disc diffusion test Antimicrobial resistance in E. coli (non-selective plates) VIBRE Project 1.00 Chicken (N=893) 0.90 Farmer (N=933) Rural, non farmer (N=919) 0.80 Urban, non farmer (N=415) Percent resistance 0.70 0.60 0.50 0.40 0.30 0.20 0.10 0.00 C TE SXT CIP1 CIP5 AK CN MEM AMP AMC CRO CAZ ESBL Diversity among chicken and human E. coli Shannon-Weaver index (H) N=5 colonies per study subject Shannon-Weaver diversity index (H) Human and chicken E. coli AMR patterns (I) 1 2 3 4 5 ---C--TE-STX----AMP- AMC---C-------AMP- ----------AMP- ----------AMP- ---C--TE-STX----- 1 -----TE-----2 ---C--TE-----AMP- X 3 ----------AMP3 ---C--TE-----AMP5 ---C--TE-STX----AMP- X Matching: 3/50 (6%) X Comparisons of E. coli patterns from humans and chickens Distances Chicken vs. farmer a Chicken vs. rural control b Chicken vs. urban control c Farmer vs. Rural control d Farmer vs. Urban control e Rural vs. Urban control f No. calculations 201 199 97 196 95 97 Median [75% IQR] 2.76 [2.07-3.40] 3.12 [2.52-4.04] 3.47 [2.68-4.15] 3.02 [2.40-3.89] 3.20 [2.52-4.22] 3.25 [2.36-4.24] Antimicrobial resistance in pig pathogens AMR among pig pathogens (n=53) Streptococcus spp. other than S. suis (N=9) 1.0 0.9 0.9 0.8 0.8 Proportion resistant Proportion resistant Staphylococcus spp. (N=10) 1.0 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0 AMP OX VA CRO CAZ CN C CIP SXT 0.0 TE AMP VA CRO CAZ CN C CIP SXT TE Gram negative coccobacilli (N=5) 1.0 0.9 0.9 0.8 0.8 Proportion resistant 1.0 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0.0 AMP OX VA CRO CAZ CN C CIP SXT TE 0.0 AMP CRO CAZ CN E C CIP TE Enterobacteriacea (N=15) 1.0 0.9 Proportion resistant Proportion resistant Streptococcus suis (N=22) OX 0.8 0.7 Source: Severe disease in piglets in southern Vietnam: main bacterial aetiologies and antimicrobial resistance. J. Campbell et al, 2014 (in preparation) 0.6 0.5 0.4 0.3 0.2 0.1 0.0 AMP CRO CAZ CN C CIP SXT TE 24 Longitudinal studies on AMR in pig and chicken farms E. coli Enterococcus spp. Environmental stressors and AMR: Quaternary ammonium compounds (QAC) Use of QAC in chicken farms Product Disinfectant class Percent farms using (%) (N=208) 1 QAC 68.2 2 Peroxygen-based 3.4 3 Halogen-Releasing agent 1 3.4 4 Halogen-Releasing agent 2 1.9 5 Other 23.0 Adaptation experiments to QAC Determine MIC for each isolate Expose 105 cfu/ml of bacteria to 0.5MIC (37oC, 18-20h) Stabilise bacteria in MHB without disinfectant (37oC, 5h) Calibrate suspension to 105cfu/ml and transfer to new MHB supplemented with 0.75 MIC QAC disinfectant Stabilise bacteria in MHB without disinfectant for 5h at 37oC Expose bacteria to step-wise increase concentration of disinfectant Until no growth observed, the highest concentration of disinfectant that bacteria can survive were used Cross-resistance QAC and antimicrobials Study ID AD01-c AD01-p AD01-ef AD02-c AD02-p AD02-ef AD03-c AD03-p AD03-ef AD04-c AD04-p AD04-ef AD09-c AD09-p AD09-ef AD10-c AD10-p AD10-ef TE S S S S R S S R R S R R S I I S I I CN S S I S S S S S I S S I S S I S S S AMP S R R S R R S R R S R R S R R S R R CIP S S S S S S S I S S S S S S S S I S CT I I I I R I I R R I R R I I R I R R SXT S S S S S S S S S S S S S S I S S S c = control; p = post adaptation; ef= after treating with PAβN C S I S S S S S I S I I I S S I S R I The link between AMU and AMR is uncontroversial Chantziaras et al (2014) Journal of Antimicrobial Chemotherapy, 69: 827-834. 30 A vociferous skeptical minority WoK quoted >350 times!!! Priorities for research….and for policy 1. Carry out farming with less antimicrobials 2. If antimicrobials are used, limit their impact on animals and their environment • Understand why and where antimicrobials are used in agriculture – Increase awareness – Change attitudes and behaviours • Surveillance of AMU and AMR: – Monitoring of antimicrobial use and ARG • Understand impact of antimicrobial use on the environmental (AM, ARG, bacteria) • Intervention studies to reduce AMU • Technical solutions to limit impact.. and test them! Acknowledgements • Zoonoses Group • ITU, CTU, Microbiology, Enterics Group • Mr. Trung Nguyen Vinh • Dr. Ngo T. Hoa • Mr. James Campbell • Dr. Constance Schultsz • Sub-Department of Animal Health Tien Giang, Dong Thap • Hospital Tropical Diseases HCMC Funding: • ZoNMW / WOTRO (The Netherlands) (VIBRE Project) • The Wellcome Trust Thanks for your attention! jcarrique-mas@oucru.org